Journey Strategic Wealth LLC decreased its holdings in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 47.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,000 shares of the company’s stock after selling 10,000 shares during the quarter. Journey Strategic Wealth LLC’s holdings in BlackRock Capital Allocation Term Trust were worth $167,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB purchased a new position in BlackRock Capital Allocation Term Trust during the fourth quarter valued at approximately $112,000. Ashton Thomas Securities LLC purchased a new position in BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $156,000. Walleye Capital LLC purchased a new position in BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $234,000. B. Riley Wealth Advisors Inc. purchased a new position in BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $238,000. Finally, Joseph P. Lucia & Associates LLC purchased a new position in BlackRock Capital Allocation Term Trust during the fourth quarter valued at approximately $255,000. Hedge funds and other institutional investors own 36.12% of the company’s stock.
BlackRock Capital Allocation Term Trust Stock Down 0.1 %
Shares of NYSE:BCAT opened at $15.44 on Tuesday. BlackRock Capital Allocation Term Trust has a 1-year low of $15.00 and a 1-year high of $17.18. The firm’s 50 day simple moving average is $15.70 and its two-hundred day simple moving average is $16.06.
BlackRock Capital Allocation Term Trust Increases Dividend
BlackRock Capital Allocation Term Trust Profile
–
Read More
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Trading Stocks: RSI and Why it’s Useful
- How to Invest in Small Cap Stocks
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- These Are the Dividend Stocks Insiders Bought in January
- Why is the Ex-Dividend Date Significant to Investors?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.